Capricor Therapeutics, Inc. (CAPR) vs Ovid Therapeutics (OVID)
Capricor Therapeutics, Inc. and Ovid Therapeutics are both Biotechnology companies. Capricor Therapeutics, Inc. and Ovid Therapeutics are of similar size ($508.7M and $487.3M). Ovid Therapeutics grew revenue faster over the last twelve months: 1,333.4% against −11.6%. Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −439.1%) and the lower return on invested capital (−1,019.7% vs −35.1%). Across the 17 metrics below, Capricor Therapeutics, Inc. leads on 9 and Ovid Therapeutics on 8.
Valuation
Profitability
| Metric | CAPR | OVID | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (742.97%) | 0.00% |
| Net margin | 0.00% | (439.11%) | 0.00% |
| Free cash flow margin | 0.00% | (697.30%) | 0.00% |
| Return on equity | (73.70%) | (25.97%) | (57.72%) |
| Return on assets | (51.53%) | (22.30%) | (49.22%) |
| Return on invested capital | (1,019.73%) | (35.11%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack